Drug product
Ranitidine Capsules 150 mg, (a) 60 count bottles (NDC 62559-690-60) , (b) 500 count bottles (NDC 62559-690-05), Rx only, Manufactured by: Appco Pharma LLC, Piscataway, NJ 08854, Distributed by: ANI Pharmaceuticals, Inc., Baudette, MN 56623.
D-0649-2020
Product summary
- Firm
- Appco Pharma LLC
- Event
- Event 84610
- Status
- Terminated
- Classification
- Class II
- Quantity
- 624 bottes
- Official record key
drug-enforcement:D-0649-2020
Official wording
Reason: CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API
Code information: Batch # 1905225VN, exp. date Apr-2021 1905226VD, exp. date Apr-2021 1906295UN, exp. date May-2021 1906296UN, exp. date May-2021 1906297UN, exp. date May-2021 1906298UD, exp. date May-2021
Distribution pattern: Product was distributed to 6 major distributors/wholesalers some with multiple locations who may have further distribute the product.
Derived failure modes
-
Foreign material or chemical contamination
Impurity N-nitrosodimethylamine (NDMA
-
Manufacturing or process control
CGMP Deviations